Journal
REVIEWS IN THE NEUROSCIENCES
Volume 24, Issue 2, Pages 115-123Publisher
WALTER DE GRUYTER GMBH
DOI: 10.1515/revneuro-2012-0071
Keywords
aggregation; dopaminergic neuron; kinase; neurotoxicity
Categories
Funding
- Global Center of Excellence Program of the Japan Society for the Promotion of Science [F03]
- Ministry of Education, Culture, Sports, Science and Technology of Japan [23591230]
- Grants-in-Aid for Scientific Research [23591230] Funding Source: KAKEN
Ask authors/readers for more resources
Parkinson's disease is the most common neuro-degenerative movement disorder. The motor impairments of Parkinson's disease are caused by the loss of dopaminergic neurons in the substantia nigra and associated with the appearance of fibrillar aggregates of alpha-synuclein (alpha-syn) called Lewy bodies. Approximately 90% of alpha-syn deposited in Lewy bodies is phosphorylated at serine 129 (Ser129). In contrast, only 4% or less of total alpha-syn is phosphorylated at this residue in the normal brain. This suggests that the accumulation of Ser129-phosphorylated alpha-syn leads to the formation of Lewy bodies and dopaminergic neurodegeneration in Parkinson's disease. Our laboratory and others have performed experiments using in vivo models of Parkinson's disease to elucidate the role of increased Ser129 phosphorylation in alpha-syn neurotoxicity. However, there has been a lack of consistency among these models. In this review, we summarize the main findings regarding the relationship between Ser129 phosphorylation and alpha-syn neurotoxicity, and examine the differences among models. We further discuss the role of Ser129 phosphorylation in alpha-syn aggregation and the future directions to test the potential of Ser129 phosphorylation as a therapeutic target for slowing the progression of Parkinson's disease.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available